0001104659-23-035233.txt : 20230321 0001104659-23-035233.hdr.sgml : 20230321 20230321193600 ACCESSION NUMBER: 0001104659-23-035233 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Munshi Amit CENTRAL INDEX KEY: 0001612551 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40598 FILM NUMBER: 23750953 MAIL ADDRESS: STREET 1: C/O EPIRUS BIOPHARMACEUTICALS, INC. STREET 2: 699 BOYLSTON STREET, 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zura Bio Ltd CENTRAL INDEX KEY: 0001855644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-247-0520 MAIL ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 600 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: JATT Acquisition Corp DATE OF NAME CHANGE: 20210407 3 1 tm2310127d8_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-03-20 0 0001855644 Zura Bio Ltd ZURA 0001612551 Munshi Amit 4225 EXECUTIVE SQUARE, SUITE 600 LA JOLLA CA 92037 1 0 0 0 Class A Ordinary Shares 499993 D Employee Share Option (Right to Buy) 8.16 2033-03-20 Class A Ordinary Shares 306373 D The Reporting Person was granted Restricted Stock Units on March 18, 2023, which shall vest in four equal, annual installments, beginning on March 18, 2024, subject to the Reporting Person's continuous employment with the Issuer. The Reporting Person was granted on March 20, 2023 the option to purchase Issuer Class A Ordinary Shares at an exercise price per ordinary share equal to the fair market value of a Class A Ordinary Share at the date of grant, which will become exercisable if the volume weighted average price of the Issuer's Class A Ordinary Shares over twenty trading days is over $30 per Class A Ordinary Share at any time prior to March 20, 2028, subject to the Reporting Person remaining as Non-Executive Chairman of the Board of Directors of the Issuer. Exhibit 24 - Power of Attorney /s/ Kimberly Ann Davis, Attorney-in-Fact 2023-03-21 EX-24 2 tm2310127d8_ex24.htm EXHIBIT 24

Exhibit 24

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that I, Amit Munshi, hereby constitute and appoint Kimberly Ann Davis my true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for me and in my name, place and stead, to sign any Form ID (Uniform Application for Access Codes to File on EDGAR), reports on Form 3 (Initial Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership of Securities) and Form 5 (Annual Statement of Beneficial Ownership of Securities) relating to transactions by me in ordinary shares or other securities of Zura Bio Limited and all amendments thereto, and to file the same, with the Securities and Exchange Commission and the appropriate securities exchange, granting unto said attorney-in-fact and agent, or her substitute, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or her substitute, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall be effective until such time as I deliver a written revocation thereof to the above-named attorney-in-fact and agent.

Dated:	3/21/2023		/s/ Amit Munshi
			Amit Munshi